back to homepage

Cost of Drugs

Popular Cancer Pill Goes Generic, Yet Patients’ Costs Stay High

Donald Jones used to pay at least $500 a month for a brand-name drug, Gleevec, that’s kept his leukemia at bay for five years. Lately, he’s been paying almost as

Read More

Affordable Health Care: Generic Drugs Not the Answer

One smart way to reduce the cost of health care, according to many experts, is to expand generic drugs. Scott Gottlieb, the new commissioner of the FDA, for example, wants

Read More

Drug prices: how generics changed the game

For a time, high drug prices made headlines, and it looked like the issue could be tackled by the Trump administration. But as we all know, efforts to repeal Obamacare

Read More

Cancer patients skipping medicines or delaying treatment due to high drug prices

John Krahne received alarming news from his doctor last December. His brain tumors were stable, but his lung tumors had grown noticeably larger. The doctor recommended a drug called Alecensa,

Read More

Can tech ease the pain of soaring drug costs?

The internet has transformed the way consumers buy everything from clothes and cars to food and movie tickets. Can the power of technology also disrupt how Americans purchase prescription drugs?

Read More

How Big Pharma Exploits the Cancer Drug Market

With another day, another headline arrives revealing the arrogant, out-of-touch nature of the pharmaceutical industry. Fortunately, this time, the outrage arrives from overseas. Specifically, the UK Independent reports that Aspen

Read More

The Billionaire And The Drug Price

In September 2015, Satish Mehta, the billionaire chief executive of the Indian drug company Emcure Pharmaceuticals, wrote an effusive email congratulating Jeffrey Glazer, the CEO of his U.S. crown jewel,

Read More

The Crazy Math Behind Drug Prices

David Hernandez, a 44-year-old restaurant worker and Type 1 diabetic, didn’t have insurance from 2011 through 2014 and often couldn’t afford insulin—a workhorse drug whose list price has risen more

Read More

Prioritizing generics — 4 strategies for lower drug costs from Dr. Scott Gottlieb

Food and Drug Administration Commissioner Scott Gottlieb, MD, outlined his strategy to lower drug prices during a Monday interview with Bloomberg. Here are four ways Dr. Gottlieb seeks to address

Read More

FDA looks at using clout to cut drug costs

The head of the U.S. Food and Drug Administration is considering using the agency’s powers to bring more price competition to the market for generic drugs, targeting high-priced products by

Read More